PCOS patients can achieve same birth rates with treatment

Tome Bio­sciences, a high-pro­file gene edit­ing start­up spun out of MIT, is halt­ing its lab work and look­ing to sell it­self or find a part­ner

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in patients with eosinophilic esophagitis at 24 weeks, a randomized phase III trial